Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health  by Shaw, Tatyana E. et al.
Eczema Prevalence in the United States: Data from
the 2003 National Survey of Children’s Health
Tatyana E. Shaw1, Gabriel P. Currie1, Caroline W. Koudelka2 and Eric L. Simpson1
Using the 2003 National Survey of Children’s Health sponsored by the federal Maternal and Child Health
Bureau, we calculated prevalence estimates of eczema nationally and for each state among a nationally
representative sample of 102,353 children 17 years of age and under. Our objective was to determine the
national prevalence of eczema/atopic dermatitis in the US pediatric population and to further examine
geographic and demographic associations previously reported in other countries. Overall, 10.7% of children
were reported to have a diagnosis of eczema in the past 12 months. Prevalence ranged from 8.7 to 18.1%
between states and districts, with the highest prevalence reported in many of the East Coast states, as well as in
Nevada, Utah, and Idaho. After adjusting for confounders, metropolitan living was found to be a significant
factor in predicting a higher disease prevalence with an odds ratio of 1.67 (95% confidence interval of 1.19–2.35,
P¼ 0.008). Black race (odds ratio 1.70, P¼ 0.005) and education level in the household greater than high school
(odds ratio 1.61, P¼ 0.004) were also significantly associated with a higher prevalence of eczema. The wide range
of prevalence suggests that social or environmental factors may influence disease expression.
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INTRODUCTION
Atopic dermatitis (AD) is a global public health concern
considering its increasing prevalence and mounting financial
costs to health systems (Lapidus et al., 1993; Ellis et al., 2002;
Carroll et al., 2005). The ISAAC (International Study of
Asthma and Allergies in Childhood) revealed that AD affects
children across the globe, although the disease prevalence
varies substantially between countries (Asher et al., 2006).
The prevalence of AD is also increasing, especially in
developing countries (Asher et al., 2006). The factors that
underlie disease prevalence, geographic variability, and
secular trends are unknown (Burney et al., 1990; Williams
et al., 1995), although industrialization and urban living are
correlated with elevated rates of atopic disease (Keeley et al.,
1991; Addo Yobo et al., 1997; Yemaneberhan et al., 1997;
Mercer et al., 2004).
Most data regarding AD prevalence in industrialized
countries are derived from the study of European populations.
Only three previous studies of AD prevalence have reported
data from a US population (Laughter et al., 2000; Asher et al.,
2006; Hanifin et al., 2007), with the scope of two of these
limited to one state. The third and most recent study did not
examine geographical trends (Hanifin et al., 2007). Further
data regarding disease prevalence, geographic variation, and
risk factors are required from the United States.
The primary objective of this study was to determine the
prevalence of AD in the United States using data obtained
from the National Survey of Children’s Health (NSCH), a
large population-based survey of 4100,000 families repre-
senting all 50 states. We examined the geographical
distribution of the disease and explored whether certain risk
factors and associations previously reported in Europe and
Asia were also present in the US population.
RESULTS
Univariate analyses
Overall, a total of 9,752 children had a diagnosis of eczema,
which translated to a 10.7% national prevalence of eczema in
children under 18 years of age. The disease prevalence ranged
from 8.7 to 18.1% between states and districts. Figure 1 and
Table 1 present state prevalence estimates for US children (0–17
years of age), who were reported to have a diagnosis of eczema
in the past 12 months. The highest state prevalence values were
reported in many East Coast states, as well as in Utah, Idaho,
and Nevada. The lowest state prevalence values were in the
middle and southwestern parts of the country (Table 1).
Of those children with eczema, 30.7% reported con-
current hay fever and 22.8% reported concurrent asthma
consistent with similar AD populations in Europe (Asher
et al., 2006; Van der Hulst et al., 2007). As expected, age
of the child was a significant determinant of eczema
prevalence, given the natural course of the disease (Table 2).
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There was a significant effect of the highest reported
education level in the household on eczema prevalence,
with those households reporting education levels greater than
high school having the greatest prevalence of eczema
(Table 2). Other significant demographic variables showing
positive associations with disease prevalence included living
in a metropolitan area (defined using RUCA (Rural-Urban
Commuting Area) codes), speaking English as the primary
language, and being of Black or multiple race (Table 2).
The birthplace of parents or child was associated
with disease prevalence. Children or parents born outside
the United States reported a lower prevalence of eczema
(Table 3). A significant association was also found with health
insurance status. Children with health insurance had greater
eczema prevalence than did those without (10.9 versus 8.2%,
P¼0.0004), possibly reflecting health-care access disparities.
Eczema prevalence showed an association with family
structure, with single mothers reporting the highest preva-
lence (Table 4). Single child homes had a higher prevalence
than did families with more than one child, but birth order
did not seem to influence disease prevalence. Children
reported to regularly receive child care had a significantly
higher prevalence of eczema than did those who did not
(Table 5), with the highest prevalence being seen in those
who attended child care outside home. Smoking in the home
showed no association with eczema prevalence.
Multivariate analysis
We developed a logistic regression model to better explain
the relationship between area of residency (metropolitan area
versus rural area) and eczema prevalence. After adjusting for
potential confounders, including race and age of child,
parental education level, household income, and health
insurance coverage status, metropolitan living continued to
be a significant factor in predicting a higher disease
prevalence with an odds ratio of 1.67 (95% confidence
interval of 1.19–2.35, P¼ 0.008) compared with rural living.
Black race (odds ratio 1.70, P¼0.005) and education level in
the household greater than high school (odds ratio 1.61,
P¼0.004) were also significantly associated with a higher
prevalence of eczema compared with White race and
education level less than high school, respectively (Table 6).
In addition to adjusting for the main effects of potential
confounders, interactive effects of insurance coverage, race,
and metropolitan residency were included in the final model
to better adjust for possible inequities in health-care access.
Statistically significant interaction terms included insurance
status by metropolitan residency (P¼ 0.047), and the three-
way interaction between insurance, race, and residency
(P¼0.04), suggesting that uninsured and insured, as well
as the different racial subgroups, may have experienced
differences in health-care access depending on their resi-
dency status.
DISCUSSION
Our large population-based study found the prevalence of
AD in the United States to be B10.7% with a significant
variation between states and districts. Urban living and being
of Black race were significantly associated with a higher
prevalence of eczema after controlling for possible con-
founders. A general geographic trend toward higher disease
prevalence in the East Coast states was also found. We
confirmed known demographic AD associations previously
observed only in European populations, including the
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Figure 1. Eczema prevalence in the United States shows a trend toward higher disease prevalence in the East Coast states.
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association of AD with higher education levels, higher
household incomes, and smaller family sizes. Notable
associations not observed in our study included a lack of
association with smoking in the household, breast feeding,
birth order, gender, or body mass index. The lack of a
correlation between body mass index and eczema is
supportive of current studies that show no relationship
between body mass index and eczema (Leung et al., 2009;
Van Gysel et al., 2009).
Our findings of an AD prevalence of 10.7% in US children
0–17 years of age agree with reported estimates from the three
previous US-based studies of AD prevalence. A study by
Hanifin reporting the results of a 1998 survey found that
17.1% of the study population had at least one of four
eczematous symptoms, whereas 10.7% of respondents
reported empirically defined eczema (Hanifin et al., 2007).
The study by Laughter et al. (2000) reported that of 1,465
Oregon schoolchildren, 5–9 years of age, a prevalence of
11.8% was found based on the question, ‘‘Has a doctor ever
said that your child has eczema?’’ Using the self-administered
Schultz Larsen questionnaire, a 17.2% lifetime prevalence
was found in that study. The global ISAAC study, in which the
United States was represented by a sample of 2,422 children
from 1 medical center in Seattle, found the prevalence of
eczema symptoms to be 8.3% (Lapidus et al., 1993). Our
study estimate was slightly higher, with a prevalence estimate
of 10.7% in the state of Washington.
Similar to the ISAAC study, which revealed striking
worldwide geographic variability in AD prevalence, our data
revealed significant geographic variability in disease pre-
valence within the United States with a higher prevalence in
the East Coast states. The reason for this variability is not
known and is likely multifactorial. One explanation may be
the presence of a higher number of metropolitan centers in
the Eastern versus Western United States. Our data revealed a
higher eczema prevalence rate in metropolitan areas even
when controlling for confounders. Several previous studies of
atopic disease have reported a similar increase in disease
prevalence in metropolitan/urban areas compared with
rural areas (Keeley et al., 1991; Addo Yobo et al., 1997;
Yemaneberhan et al., 1997; Laughter et al., 2000; Mercer
Table 1. Eczema prevalence by state
State/district Frequency1 Percentage2
95% Confidence
interval
West Virginia 159 8.69 (7.21, 10.18)
South Dakota 136 8.69 (6.93, 10.46)
California 180 8.74 (7.26, 10.22)
New Mexico 142 8.74 (7.08, 10.39)
Iowa 159 8.78 (7.27, 10.30)
Vermont 154 8.92 (7.30, 10.54)
Arkansas 139 9.02 (7.31, 10.73)
Florida 159 9.07 (7.34, 10.80)
Mississippi 147 9.37 (7.56, 11.19)
Wisconsin 162 9.39 (7.78, 11.00)
Texas 174 9.69 (8.08, 11.30)
Pennsylvania 200 9.70 (8.18, 11.23)
Hawaii 173 9.73 (8.04, 11.43)
Nebraska 147 9.88 (8.09, 11.66)
New Hampshire 179 9.88 (8.35, 11.41)
Missouri 189 9.94 (8.36, 11.52)
Oklahoma 165 10.03 (8.36, 11.71)
North Dakota 154 10.12 (8.31, 11.93)
Tennessee 176 10.26 (8.49, 12.03)
Kansas 156 10.26 (8.40, 12.11)
Illinois 203 10.29 (8.61, 11.98)
Wyoming 168 10.35 (8.67, 12.02)
Indiana 164 10.66 (8.84, 12.48)
Washington 190 10.72 (9.07, 12.37)
Arizona 152 10.79 (8.86, 12.71)
Alaska 165 10.93 (9.08, 12.78)
Colorado 194 10.93 (9.21, 12.65)
Maine 187 11.14 (9.36, 12.92)
Montana 185 11.17 (9.38, 12.96)
Delaware 228 11.26 (9.67, 12.86)
South Carolina 208 11.30 (9.60, 13.00)
Ohio 220 11.32 (9.66, 12.97)
Minnesota 168 11.36 (9.39, 13.32)
Oregon 188 11.49 (9.69, 13.29)
North Carolina 204 11.51 (9.75, 13.27)
Connecticut 241 11.56 (9.93, 13.20)
Kentucky 204 11.57 (9.80, 13.33)
Alabama 216 11.63 (9.84, 13.41)
Michigan 222 11.68 (9.98, 13.39)
Virginia 220 11.73 (9.97, 13.49)
New York 222 11.75 (10.01, 13.49)
Idaho 169 11.82 (9.93, 13.71)
Georgia 192 11.93 (10.00, 13.86)
New Jersey 270 13.14 (11.36, 14.91)
Table 1. Continued
State/district Frequency1 Percentage2
95% Confidence
interval
Maryland 261 13.20 (11.37, 15.03)
Massachusetts 265 13.44 (11.65, 15.23)
Utah 169 13.52 (11.39, 15.65)
Rhode Island 258 13.56 (11.68, 15.45)
Louisiana 250 13.70 (11.74, 15.66)
Nevada 226 14.17 (12.17, 16.18)
District of Columbia 293 18.05 (15.64, 20.45)
1Raw frequency of surveyed subjects with eczema.
2Weighted percentage of state pediatric population with eczema.
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et al., 2004). Potential explanations for this phenomenon
include metropolitan-related environmental factors, such as
exposure to environmental pollution (Asher et al., 2006). For
example, an increased prevalence of allergic disease in
Ethiopia was associated with the use of modern fuels,
particularly kerosene use in homes (when compared with
other biomass fuel) (Venn et al., 2001). Another possibility
noted by von Hertzen and Haahtela (2006) was the heavy
exposure to microorganisms in soil and vegetation when
living in rural farming areas. Cultural and behavioral factors
that affect the skin barrier may also have a role. Sherriff et al.
(2002) found a correlation between an increased hygiene
score (that included the frequency of washing/wiping hands
and faces and bathing practices of young children) and
Table 2. Eczema prevalence stratified by primary demographic variables
Variable Subgroup Frequency1 Percentage2 95% Confidence interval P-value3
Age o4 years 2,977 13.92 (13.12, 14.73) o0.0001
4–8 years 2,623 10.63 (9.98, 11.27)
9–12 years 1,862 9.96 (9.23, 10.68)
13–17 years 2,290 8.56 (7.97, 9.16)
Gender Male 4,874 10.52 (10.04, 11.01) 0.3507
Female 4,867 10.85 (10.36, 11.34)
Highest education level completed by parent oHS 278 6.95 (5.63, 8.27) o0.0001
HS 1,721 9.61 (8.89, 10.33)
4HS 7,721 11.47 (11.06, 11.88)
Residence in metropolitan area No 1,442 8.53 (7.90, 9.16) o0.0001
Yes 5,161 10.99 (10.55, 11.43)
Primary language spoken at home English 9,273 11.15 (10.78, 11.51) o0.0001
Any other 474 6.91 (5.89, 7.94)
Race White only 6,770 9.70 (9.34, 10.05) o0.0001
Black only 1,464 15.89 (14.64, 17.14)
Multiple race 550 15.03 (12.97, 17.10)
Other 470 10.08 (8.36, 11.80)
Household income 0–99% FPL 1,037 10.38 (9.40, 11.37) 0.0357
100–199% FPL 1,732 11.09 (10.18, 12.00)
200–399% FPL 3,135 10.21 (9.65, 10.77)
X400% FPL 3,024 11.53 (10.91, 12.15)
Abbreviations: FPL, federal poverty level; HS, high school.
1Raw frequency of surveyed subjects with eczema.
2Weighted percentage of subgroup population with eczema.
3Rao–Scott w2 test for equal proportions.
Table 3. Eczema prevalence stratified by birthplace variables
Variable Subgroup Frequency1 Percentage2 95% Confidence interval P-value3
Child’s mother born in the United States No 912 9.08 (8.09, 10.07) 0.0004
Yes 8,352 11.14 (10.76, 11.52)
Child’s father born in the United States No 739 9.27 (8.15, 10.39) 0.0297
Yes 6,508 10.66 (10.24, 11.07)
Child born in the United States No 233 6.80 (5.28, 8.32) o0.0001
Yes 9,431 10.84 (10.49, 11.19)
1Raw frequency of surveyed subjects with eczema.
2Weighted percentage of subgroup population with eczema.
3Rao–Scott w2 test for equal proportions.
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Table 4. Eczema prevalence stratified by family structure variables
Variable Subgroup Frequency1 Percentage2 95% Confidence interval P-value3
Number of children in household One child 4,149 11.82 (11.30, 12.35) 0.0039
Two children 3,700 10.75 (10.25, 11.24)
Three children 1,382 10.07 (9.29, 10.86)
Four or more children 521 9.78 (8.52, 11.04)
Birth order in families with two or more children Oldest child 2,182 9.72 (9.10, 10.33) 0.1098
Second oldest child 2,590 10.97 (10.34, 11.59)
Third oldest child 640 10.07 (8.88, 11.26)
Fourth oldest child 191 11.14 (8.75, 13.52)
Family structure Two-parent biological/adopted 6,378 10.68 (10.26, 11.10) 0.0013
Two-parent stepfamily 680 9.97 (8.70, 11.23)
Single mother/no father present 2,179 11.42 (10.65, 12.20)
Other 296 7.68 (6.14, 9.22)
1Raw frequency of surveyed subjects with eczema.
2Weighted percentage of subgroup population with eczema.
3Rao–Scott w2 test for equal proportions.
Table 5. Eczema prevalence stratified by environmental variables
Variable Subgroup Frequency1 Percentage2 95% Confidence interval P-value3
During the past month did child regularly attend a child-care center? No 2,508 11.60 (10.89, 12.31) o0.0001
Yes 1,598 15.41 (14.14, 16.67)
Does anyone in the household use cigarettes, cigars, or pipe tobacco? No 5,717 10.40 (9.96, 10.83) 0.8966
Yes 2,413 10.45 (9.78, 11.12)
1Raw frequency of surveyed subjects with eczema.
2Weighted percentage of subgroup population with eczema.
3Rao–Scott w2 test for equal proportions.
Table 6. Subgroup comparisons of variables included in multivariate model
Variable Contrast Odds ratio SE 95% Confidence interval P-value1
Residence in metropolitan area Metro versus rural 1.67 0.29 (1.19, 2.35) 0.0079
Race Black versus white 1.70 0.29 (1.22, 2.37) 0.0048
Multiple race versus white 0.84 0.18 (0.56, 1.27) 0.5033
Other versus white 0.95 0.22 (0.60, 1.49) 0.8513
Age category o4 years versus 13–17 years 1.77 0.11 (1.57, 2.00) o0.0001
4–8 years versus 13–17 years 1.27 0.08 (1.13, 1.43) 0.0006
9–12 years versus 13–17 years 1.15 0.08 (1.01, 1.31) 0.0640
Highest education level completed by parent HS versus oHS 1.34 0.20 (1.00, 1.78) 0.0799
4HS versus oHS 1.61 0.23 (1.21, 2.13) 0.0038
Income as a percentage of poverty level 100–199% versus 0–99% 1.11 0.09 (0.94, 1.31) 0.2938
200–399% versus 0–99% 0.99 0.08 (0.84, 1.15) 0.8513
X400% versus 0–99% 1.13 0.09 (0.96, 1.32) 0.2304
1Wald w2 test adjusted for multiple comparisons by false discovery rate method.
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subsequent eczema risk. Whether skin care practices vary
between rural and metropolitan inhabitants is not known.
An unexpected association in our study was the greater
prevalence of eczema in Black and multirace populations
compared with Whites. Hanifin did not find statistically
significant differences between various race populations and
their prevalence of eczema. A few previous studies have
reported racial disparities in eczema prevalence (Davis et al.,
1961; Schachner et al., 1983; Williams et al., 1995). In the
most recent study, Williams et al. (1995) found a higher
prevalence of AD in Black Caribbean individuals in London
compared with Whites. Using medical care usage as a proxy
for disease prevalence, Horii et al. (2007) reported an
increased use of medical care for AD by Blacks and Asian/
Pacific Islanders when compared with Whites. It is not known
whether these racial differences derive from environmental or
genetic influences. There are no large studies of the
prevalence of common filaggrin mutations in an African
population. Studies in asthma have also reported similar
racial disparities and differences in socioeconomic status and
air quality have been proposed as the possible explanations
(Gorman, 2009).
A significant limitation of our study was that we could
not be certain whether geographic differences in disease
prevalence reflected differences in access to medical care or
dermatological specialty care. There are fewer dermatologists
per capita in rural areas compared with urban areas, although
wait time to be seen by a dermatologist was not statistically
different between urban and rural areas (Uhlenhake et al.,
2009). Our regression model controlled for this issue, but this
does not eliminate the potential bias completely. Another
limitation of this study was the nature of the self-reported
survey data collection. Diagnoses were not confirmed by a
chart review or direct examination of the patients. Single
questions addressing parent recall of physician-diagnosed
eczema that have been validated and used in other
prevalence studies reported a high concordance between
using a similar single question (‘‘Has a doctor ever said that
your child has eczema?’’) with direct clinical examination
and questionnaire diagnosis of AD (Laughter et al., 2000).
Another study from Germany tested the validity of the
diagnosis of AD using the question, ‘‘Has a physician ever
diagnosed eczema in your child?’’ It showed 63% sensitivity
and 88% specificity using dermatological exam as the gold
standard (Kramer et al., 1998). On the basis of the results of
these studies, the wording of the question in this survey has
adequate sensitivity and specificity to provide meaningful
data on eczema prevalence. Finally, these survey data are
now 7 years old.
MATERIALS AND METHODS
Data source
We used data obtained from the 2003 NSCH survey of 102,353
households, which was designed to estimate the prevalence of
various child health issues, including physical, emotional, and
behavioral factors. The NSCH was sponsored by the Maternal and
Child Health Bureau and the US Department of Health and Human
Services. The National Center for Health Statistics conducted a total
of 102,353 interviews using the SLAITS (State and Local Area
Integrated Telephone Survey) program. The telephone numbers
were chosen at random, followed by identification of the households
with one or more children under the age of 18 years. Subsequently,
one child was randomly selected for interview. The survey results
were weighted to represent the population of noninstitutionalized
children nationally and in each state. Using data obtained from the
US Bureau of the Census, weights were adjusted for age, sex, race,
ethnicity, household size, and educational attainment of the most
educated household member to provide a data set that was more
representative of each state’s population of noninstitutionalized
childreno18 years of age. The National Center for Health Statistics
of Center for Diseases Control and Prevention oversaw sampling and
telephone interviews. More detailed information on the survey has
been previously published (Blumberg et al., 2005).
Study variables
We calculated the period prevalence of AD/eczema using the NSCH
question, ‘‘During the past 12 months, have you been told by a
doctor or other health professional that (child’s name) had eczema or
any kind of skin allergy?’’
To limit the effect health-care access may have on the results, we
excluded all subjects who responded ‘‘no’’ to the question, ‘‘During
the past 12 months, did (child) see a doctor, nurse, or other health
care professional for any kind of medical care, including sick-child
care, well-child check-ups, physical exams, and hospitalizations?’’
We also included health-care insurance status in our final regression
model when we examined the role of metropolitan living on AD
prevalence.
NSCH data were interpreted to calculate the national prevalence
of eczema for the United States and for each state. Further
investigation into the influences of race, geography, socioeconomic
status, education levels, family size, place of residence, and birth
order was performed based on previously described associations in
the literature found in European populations (Hanifin, 2009).
Statistical methods
Analyses were performed using SURVEY procedures in SAS version
9.2 (SAS, Cary, NC, USA). Univariate associations were tested by the
Rao–Scott w2 method. Multivariate results were obtained by logistic
regression for domains of weighted survey data. Regression analysis
did not include data from many states (including Alaska, Connecticut,
Delaware, Hawaii, Idaho, Maine, Maryland, Massachusetts,
Montana, Nevada, New Hampshire, North Dakota, Rhode Island,
South Dakota, Vermont, and Wyoming) for which metropolitan
residency status was unavailable. The regression model used
residency status (metropolitan versus rural) to predict diagnosis of
pediatric eczema while controlling for potential demographic
confounders, including race and age and health insurance coverage
status. The number of children living in the home was not
significantly associated with eczema diagnosis; therefore, this
variable was removed to simplify the model. Interactive effects
between race, insurance status, and metropolitan residency were
included in an attempt to better control for inequity in health-care
access between races and areas of residency. Odds ratios for specific
demographic comparisons were determined using the final multi-
variate model, and their P-values were adjusted for multiple
comparisons using the false discovery rate method (Table 6).
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